Sign Up Today and Learn More About MediMabBio Stock
Invest in or calculate the value of your shares in MediMabBio or other pre-IPO companies through EquityZen's platform.
MediMabBio Stock
MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.
About MediMabBio Stock
Founded
2017
Industries
Science and Engineering, Health Care, Biotechnology
MediMabBio Press Mentions
Stay in the know about the latest news on MediMabBio
Fusion protein comprising antibody binding specifically to tigit and …
patents • May 18, 2025
Anti-tigit antibodies and use thereof
patents • Apr 05, 2025
MediMabBio Management
Leadership team at MediMabBio
Founder and Co-CEO
Yu-Hoi Kang
Join now and verify your accreditation status to gain access to:
- MediMabBio Current Valuation
- MediMabBio Stock Price
- MediMabBio Management
- Available deals in MediMabBio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- MediMabBio Cap Table and Funding History by Share Class and Liquidity Preferences
- MediMabBio Revenue and Financials
- MediMabBio Highlights
- MediMabBio Business Model
- MediMabBio Risk Factors
- MediMabBio Research Report from SACRA Research
Trading MediMabBio Stock
How to invest in MediMabBio stock?
Accredited investors can buy pre-IPO stock in companies like MediMabBio through EquityZen funds. These investments are made available by existing MediMabBio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MediMabBio stock?
Shareholders can sell their MediMabBio stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."